Sources
Sources and methodology
Tablet Compare uses public sources to classify availability, provider readiness and comparison context.
Source types
We prioritise regulator pages, medicine information pages, manufacturer announcements, provider pages and visible provider warnings or update forms.
Classification method
Provider-readiness rows describe visible public signals. They are not endorsements, clinical advice or guarantees of future access.
Core sources checked for launch
- GOV.UK GLP-1 medicines guidance
- MHRA Wegovy pen approval update
- FDA novel drug approvals 2026
- Eli Lilly Foundayo approval announcement
- Rybelsus Summary of Product Characteristics
Last reviewed: 9 May 2026